Amne Borghol

Dr. Amne Borghol

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
IOIfeanyichukwu Onor
Ifeanyichukwu Onor
DSDaniel L. Stirling
Daniel L. Stirling
SWShandrika Williams
Shandrika Williams
DBDaniel Bediako
Daniel Bediako
ABAmne Borghol
Amne Borghol
Daniel F. SarpongDaniel F. Sarpong
Daniel F. Sarpong
Cigarette smoking—a crucial modifiable risk factor for organ system diseases and cancer—remains prevalent in the United States and globally. In this literature review, we aim to summarize the epidemiology of cigarette smoking and tobacco use in the United States, pharmacology of nicotine—the active constituent of tobacco, and health consequence of cigarette smoking. This article also reviews behavioral and pharmacologic interventions for cigarette smokers and provides cost estimates for approved pharmacologic interventions in the United States. A literature search was conducted on Google Scholar, EBSCOhost, ClinicalKey, and PubMed databases using the following headings in combination or separately: cigarette smoking, tobacco smoking, epidemiology in the United States, health consequences of cigarette smoking, pharmacologic therapy for cigarette smoking, and non-pharmacologic therapy for cigarette smoking. This review found that efficacious non-pharmacologic interventions and pharmacologic therapy are available for cessation of cigarette smoking. Given the availability of efficacious interventions for cigarette smoking cessation, concerted efforts should be made by healthcare providers and public health professionals to promote smoking cessation as a valuable approach for reducing non-smokers’ exposure to environmental tobacco smoke.

12 October 2023 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
IOIfeanyiChukwu O. Onor
IfeanyiChukwu O. Onor
FAFahamina Ahmed
Fahamina Ahmed
ANAnthony N. Nguyen
Anthony N. Nguyen
MEMichael C. Ezebuenyi
Michael C. Ezebuenyi
COCollins Uchechukwu Obi
Collins Uchechukwu Obi
EREfrain Reisin
Efrain Reisin

24 November 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
IOIfeanyichukwu Onor
Ifeanyichukwu Onor
LHLashira M. Hill
Lashira M. Hill
MFModupe M. Famodimu
Modupe M. Famodimu
MCMallory R. Coleman
Mallory R. Coleman
CHCarolkim H. Huynh
Carolkim H. Huynh
SGShane G. Guillory
Shane G. Guillory
The role of magnesium in blood pressure has been studied among hypertensive patients; however, there is a dearth of studies exploring the role of magnesium in hypertensive crises. The primary objective of this study was to evaluate the relationship between serum magnesium and blood pressure in patients with hypertensive crises. This was a single-center, retrospective, chart review, cross-sectional study of patients with hypertensive crises. Patients were included if they were eighteen years of age or older, with an international classification disease ninth revision (ICD-9) code of 401.9 (hypertensive crises: emergency or urgency) and a documented magnesium level on their electronic medical record. The primary outcome of the study was the correlation between serum magnesium and blood pressure (systolic blood pressure and diastolic blood pressure) in patients with hypertensive crises. Two hundred and ninety-three patients were included in the study. The primary outcome result showed that serum magnesium was positively correlated with systolic blood pressure (r = 0.143, p = 0.014), but not diastolic blood pressure. Conclusion: This study found a significant positive association between magnesium and systolic blood pressure, but not diastolic blood pressure, among patients with hypertensive crises. This positive association of serum magnesium with systolic blood pressure was maintained after adjusting for covariates. This study’s findings suggest a potential role of magnesium in blood pressure among patients with hypertensive crises.

1 April 2018
Verified
Journal Article
Closed access
ABAmne Borghol
Amne Borghol
MAMichael Aucoin
Michael Aucoin
IOIfeanyichukwu Onor
Ifeanyichukwu Onor
DJDana Jamero
Dana Jamero
FHFadi Hawawini
Fadi Hawawini

21 April 2020 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
ABAmne Borghol
Amne Borghol
IOIfeanyichukwu Onor
Ifeanyichukwu Onor
ANAlison Neuliep
Alison Neuliep
AZAhmed Zaki
Ahmed Zaki
GAGabriela Andonie
Gabriela Andonie
FAFahamina Ahmed
Fahamina Ahmed

1 May 2024 in Journal of Opioid Management
Verified
Journal Article
Closed access
PDF file
ABAmne Borghol
Amne Borghol
FAFahamina Ahmed
Fahamina Ahmed
DJDana Jamero
Dana Jamero
HCHelen Calmes
Helen Calmes
TMTaylor Monthey
Taylor Monthey
SMSonia Malhotra
Sonia Malhotra
Objective: Electronic prescriptions are now the standard of practice for all discharge and outpatient prescriptions. The intention is to increase patient safety, provide a more complete medication record for patients, lessen the burden on prescribers, and shorten the time it takes for medication orders to reach the pharmacy. Design: This cross-sectional questionnaire survey study was conducted between January and August 2022 in three areas of a large urban safety net hospital. Setting: A large single academic medical center. Participants: Emergency department, inpatient clinicians, and procedural areas. The subjects of the study were trainees, attending physicians, and advance practice providers (APPs) Interventions: Data were collected from the participants using a self-reported questionnaire, including sociodemographic characteristics, ease of use, reliability, and preference. Additionally, the perception of the strengths and limitations associated with electronic prescribing (e-prescribing) were analyzed. Main outcome measure: The purpose of this study was to evaluate the barriers to e-prescribing of opioids. Results: A total of 121 prescribers completed the survey. The majority trusted that e-prescribing were transmitted successfully (62 percent), saved time (78 percent), and did not interrupt their workflow (78 percent). However, many prescribers indicated that additional improvements are needed, such as updating the patient’s preferred pharmacy in the electronic medical record during each visit (52 percent) and having a 24-hour pharmacy readily available (66 percent). Conclusion: Prescribers value the ease of use of e-prescribing and how time efficient the process can be. Nevertheless, there is a need to improve the system’s service, design, and usefulness.